Navigation Links
ArcMesa Educators Appoints Medical Advisor and Directors to CME Development Team
Date:9/27/2007

Clinical Experience, Advanced Scientific Knowledge, Highlight Most Recent

Growth

MONROE, N.J., Sept. 27 /PRNewswire/ -- ArcMesa Educators, an accredited provider of continuing education courses, is proud to announce the addition of three talented individuals to its staff. Backed by years of scientific experience and advanced degrees in molecular biology, structural biology, biochemistry/biophysics, and biomedical sciences from the top universities across the nation, each brings a wealth of clinical expertise and scientific rigor. With concentrations in oncology, cardiovascular disease, endocrinology, neurobiology, hypertension, gender-specific medicine, anemia, MS, virology and a host of other therapeutic-specific areas, Dr. Eugene R. Tombler, Dr. Kirk Tacka, and Dr. Duke Duguay offer various proficiencies that will fuel the next generation of medical education program development.

"It's a pleasure to have Dr. Tombler, Dr. Tacka, and Dr. Duguay on the CME development team at ArcMesa," said Tighe Blazier, President of ArcMesa Educators. "We are proud to add their scientific expertise to the CME activities we produce. The result is educational materials that medical professionals appreciate and implement in their jobs as we all work together toward better patient care."

Eugene R. Tombler, PhD, Senior Medical Advisor, is a graduate of the Mount Sinai School of Medicine of NYU, where he earned his PhD in the biomedical sciences with a strong diversified background on prostate cancer and neurobiology. As senior medical advisor, Dr. Tombler will serve as the main point of contact with grantors and thought leaders and will be responsible for directly supervising gap analyses, conducting needs assessments, and developing program proposals.

Kirk Tacka, PhD, Assistant Medical Director, is a graduate of Syracuse University, where he earned his PhD in structural biology, biochemistry, and biophysics. With a multidisciplinary training background, he is proficient in drug pharmacology, cell/molecular biology, and physical chemistry. At ArcMesa Educators, Dr. Tacka will assist business development by conducting needs assessments and reviewing proposals, in addition to ensuring programming is scientifically accurate, fair balanced, and ACCME-compliant. Dr. Tacka's role also includes identifying and consulting with key opinion leaders within oncology, cardiovascular disease, and other therapeutic areas.

Duke Duguay, PhD, Assistant Medical Director, is a graduate of Princeton University, where he earned his PhD and MA in molecular biology, and the University of California at Berkeley, where he earned a BA in molecular and cell biology. As assistant medical director, Dr. Duguay will assist with writing educational grants, developing scientific content, supervising freelance writers, and ensuring clinical/scientific accuracy and the necessary fair balance/compliancy rules for all of ArcMesa Educator's scientific programs.

About ArcMesa Educators, LLC

ArcMesa Educators (http://www.arcmesa.com) is a provider of continuing education courses for professionals. Through http://www.CMEdiscovery.com, http://www.OncoUniveristy.com, http://www.NeuroUniversity.com, and http://www.AutoImmuneUniversity.com, ArcMesa Educators offers CME activities to physicians, pharmacists, and nurses. ArcMesa Educators, a full service content developer, holds multiple accreditations including the Accreditation Council for Continuing Medical Education (ACCME) AMA PRA Category 1, the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC). ArcMesa Educators is dedicated to delivering relevant and current medical content via innovative, high-quality CME activities that improve performance and promote better patient care.


'/>"/>
SOURCE ArcMesa Educators
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Businesses and educators to preview video games for training
2. Exporting The Wisconsin Idea - British Educators Study UW for Role Model of the Future
3. Sharon Ethanol appoints operations director
4. Kyron appoints former AMA chairman to board
5. Brady appoints GE efficiency expert as CTO
6. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
7. Johnson Controls appoints Roell to head EOC
8. SecurePipe appoints two senior execs
9. Milwaukees PointOne appoints new president and CEO
10. Third Wave appoints new chairman
11. Midwest Venture Summit disappoints; Cato grades Midwest governors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... January 18, 2017 , ... Opal Kelly, a leading ... PCI Express, announced the ZEM5310 USB 3.0 FPGA Module, combining a SuperSpeed USB ... sized form factor suitable for prototyping, testing, and production-ready integration. The ZEM5310 USB ...
(Date:1/18/2017)... , Jan. 18, 2017   Boston Biomedical ... compounds designed to target cancer stemness pathways, will feature ... compound, napabucasin, at the 2017 ASCO Gastrointestinal Cancers Symposium, ... . Napabucasin is an orally-administered ... targeting STAT3. i Cancer stem cells (CSCs) possess ...
(Date:1/18/2017)... 2017   Parent Project Muscular Dystrophy (PPMD) , ... Duchenne muscular dystrophy (Duchenne) , today announced a $600,000 ... of Technology (NJIT) and Talem Technologies (Talem) as part ... to assist people living with Duchenne. PPMD is ... an embedded computer, software, a force sensor and a ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... that Dr. Dante Leven successfully implanted SpineFrontier’s A-CIFT™ Solofuse-P™. The operation took place ... in Valley Stream, NY. The procedure was an anterior cervical discectomy and fusion ...
Breaking Biology Technology:
(Date:12/22/2016)... December 22, 2016 SuperCom (NASDAQ: ... solutions for the e-Government, Public Safety, HealthCare, and Finance sectors announced ... has been selected to implement and deploy a community-based supportive services ... Northern California , further expanding its presence in the state. ... This new program, ...
(Date:12/19/2016)... España y TORONTO , 19 de diciembre de ... Biologics Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo ... varios tipos de tumor en 2017, con múltiples sitios previstos a ... ... con objetivo en el factor inhibidor de leucemia (LIF), una citoquina ...
(Date:12/16/2016)... 2016 The global wearable medical device market, in terms ... from USD 5.31 billion in 2016, at a CAGR of 18.0% ... ... advancements in medical devices, launch of a growing number of smartphone-based ... among healthcare providers, and increasing focus on physical fitness. ...
Breaking Biology News(10 mins):